...
【24h】

Does nasal congestion have a role in decreased resistance to regular CPAP usage?

机译:鼻塞是否具有对常规CPAP使用的抵抗力下降的作用?

获取原文
获取原文并翻译 | 示例
           

摘要

Nasal obstruction is known to cause resistance to continuous positive airway pressure (CPAP) therapy in obstructive sleep apnea syndrome (OSAS). In this paper, short- and long-term nasal congestion in OSAS patients receiving CPAP treatment were evaluated with acoustic rhinometry (AR). A total of 36 patients with moderate-to-severe OSAS, diagnosed with polysomnography were included in the study. Ten healthy subjects without OSAS constituted the control group. Pre-treatment nasal patency were measured with AR in all participants. 26 patients used the recommended CPAP treatment. Ten patients did not accept CPAP treatment. The AR test was repeated for all the subjects after 1 and 3 months except the 3rd month's measurements of the control group. There was no statistically significant difference between the initial minimum cross-sectional area (MCA) measurements of OSAS patients, using or not using CPAP, and the control group (P > 0.05). However, the first month MCA measurements of patients receiving CPAP were found to be significantly decreased compared with the initial values (P 0.05). No significant difference revealed in the 3rd month MCA measurements of the patients using CPAP compared with the initial values (P > 0.05). In this study, the increased nasal congestion, which is thought to be the cause of CPAP resistance, was objectively demonstrated in OSAS patients using CPAP. In addition, the nasal congestion developing at the first month was shown to disappear over time, supporting the opinion that patient compliance in CPAP treatment is expected to increase after regular device usage.
机译:已知鼻梗阻造成阻塞性睡眠呼吸暂停综合征(OSAS)对连续正气道压力(CPAP)治疗的抵抗力。在本文中,用声鼻窦测压法(AR)评估接受CPAP处理的OSAS患者的短期和长期鼻塞。研究中共有36例中度至严重的OSA,诊断患有多瘤创造术中的研究。没有OSA的十个健康受试者构成了对照组。在所有参与者中用AR测量前治疗前鼻腔通畅。 26例患者使用推荐的CPAP治疗。十名患者不接受CPAP治疗。除了第3个月之外的所有受试者,除了第3个月的对照组进行后,将重复AR测试。 OSAS患者的初始最小横截面积(MCA)测量之间没有统计学上有显着差异,使用CPAP和对照组(P> 0.05)。然而,与初始值相比,发现接受CPAP的患者的第一个月MCA测量值得显着降低(P 0.05)。与初始值相比,使用CPAP的患者的第3个月MCA测量没有显着差异(P> 0.05)。在本研究中,在使用CPAP的OSAS患者中旨在展示被认为是CPAP抗性的原因的增加的鼻塞。此外,在第一个月开发的鼻塞血布显示随着时间的推移,支持患者遵守CPAP治疗的意见预计经常设备使用后会增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号